Skip to main content
Quest Diagnostics

Assessment of Known and Newly Discovered IGF-1 Variants by a High-throughput Clinical Reference Laboratory

AACC/ADLM 2024

The Association for Diagnostics & Laboratory Medicine (formerly ACC)

Chicago, IL, July 28-Aug 1, 2024

Poster presentation: Assessment of Known and Newly Discovered IGF-1 Variants by a High-throughput Clinical Reference Laboratory

Authors: Motorykin I, Li EM, Li H, McPhaul MJ, Clarke NJ, Wu Z

Specialty: Endocrinology, Cardiology

Related content

Publication
Isotopic Peak Index, Relative Retention Time, and Tandem MS for Automated High Throughput IGF-1 Variants Identification in a Clinical Laboratory
Publication
Detection Rate of IGF-1 Variants and Their Implication to Protein Binding: Study of Over 240,000 Patients
Conference Presentation
Detection of an unusual IGF-2 species using high-resolution mass spectrometry during a routine IGF-1 clinical assay

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.